Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2005 1
2006 1
2007 1
2012 1
2013 2
2014 2
2015 4
2016 4
2017 5
2018 5
2019 5
2020 6
2021 13
2022 14
2023 16
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
Page 1
SARS-CoV-2 escape from cytotoxic T cells during long-term COVID-19.
Stanevich OV, Alekseeva EI, Sergeeva M, Fadeev AV, Komissarova KS, Ivanova AA, Simakova TS, Vasilyev KA, Shurygina AP, Stukova MA, Safina KR, Nabieva ER, Garushyants SK, Klink GV, Bakin EA, Zabutova JV, Kholodnaia AN, Lukina OV, Skorokhod IA, Ryabchikova VV, Medvedeva NV, Lioznov DA, Danilenko DM, Chudakov DM, Komissarov AB, Bazykin GA. Stanevich OV, et al. Among authors: lioznov da. Nat Commun. 2023 Jan 10;14(1):149. doi: 10.1038/s41467-022-34033-x. Nat Commun. 2023. PMID: 36627290 Free PMC article.
The rise and spread of the SARS-CoV-2 AY.122 lineage in Russia.
Klink GV, Safina KR, Nabieva E, Shvyrev N, Garushyants S, Alekseeva E, Komissarov AB, Danilenko DM, Pochtovyi AA, Divisenko EV, Vasilchenko LA, Shidlovskaya EV, Kuznetsova NA; Coronavirus Russian Genetics Initiative (CoRGI) Consortium; Speranskaya AS, Samoilov AE, Neverov AD, Popova AV, Fedonin GG; CRIE Consortium; Akimkin VG, Lioznov D, Gushchin VA, Shchur V, Bazykin GA. Klink GV, et al. Among authors: lioznov d. Virus Evol. 2022 Mar 5;8(1):veac017. doi: 10.1093/ve/veac017. eCollection 2022. Virus Evol. 2022. PMID: 35371558 Free PMC article.
Spread of endemic SARS-CoV-2 lineages in Russia before April 2021.
Klink GV, Safina KR, Garushyants SK, Moldovan M, Nabieva E, Komissarov AB, Lioznov D, Bazykin GA; CoRGI (Coronavirus Russian Genetic Initiative) Consortium. Klink GV, et al. Among authors: lioznov d. PLoS One. 2022 Jul 20;17(7):e0270717. doi: 10.1371/journal.pone.0270717. eCollection 2022. PLoS One. 2022. PMID: 35857745 Free PMC article.
The rise and spread of the SARS-CoV-2 AY.122 lineage in Russia.
Klink GV, Safina K, Nabieva E, Shvyrev N, Garushyants S, Alekseeva E, Komissarov AB, Danilenko DM, Pochtovyi AA, Divisenko EV, Vasilchenko LA, Shidlovskaya EV, Kuznetsova NA; Coronavirus Russian Genetics Initiative (CoRGI) Consortium; Samoilov AE, Neverov AD, Popova AV, Fedonin GG; CRIE Consortium; Akimkin VG, Lioznov D, Gushchin VA, Shchur V, Bazykin GA. Klink GV, et al. Among authors: lioznov d. medRxiv [Preprint]. 2021 Dec 5:2021.12.02.21267168. doi: 10.1101/2021.12.02.21267168. medRxiv. 2021. PMID: 34909799 Free PMC article. Updated. Preprint.
Immunogenicity and safety of a recombinant adenovirus type-5 COVID-19 vaccine in adults: Data from a randomised, double-blind, placebo-controlled, single-dose, phase 3 trial in Russia.
Lioznov D, Amosova I, Sheetikov SA, Zornikova KV, Serdyuk Y, Efimov GA, Tsyferov M, Khmelevskii M, Afanasiev A, Khomyakova N, Zubkov D, Tikhonov A, Zhu T, Barreto L, Dzutseva V. Lioznov D, et al. PLoS One. 2023 Mar 8;18(3):e0278878. doi: 10.1371/journal.pone.0278878. eCollection 2023. PLoS One. 2023. PMID: 36888640 Free PMC article. Clinical Trial.
Genomic epidemiology of the early stages of the SARS-CoV-2 outbreak in Russia.
Komissarov AB, Safina KR, Garushyants SK, Fadeev AV, Sergeeva MV, Ivanova AA, Danilenko DM, Lioznov D, Shneider OV, Shvyrev N, Spirin V, Glyzin D, Shchur V, Bazykin GA. Komissarov AB, et al. Among authors: lioznov d. Nat Commun. 2021 Jan 28;12(1):649. doi: 10.1038/s41467-020-20880-z. Nat Commun. 2021. PMID: 33510171 Free PMC article.
Final efficacy analysis, interim safety analysis, and immunogenicity of a single dose of recombinant novel coronavirus vaccine (adenovirus type 5 vector) in adults 18 years and older: an international, multicentre, randomised, double-blinded, placebo-controlled phase 3 trial.
Halperin SA, Ye L, MacKinnon-Cameron D, Smith B, Cahn PE, Ruiz-Palacios GM, Ikram A, Lanas F, Lourdes Guerrero M, Muñoz Navarro SR, Sued O, Lioznov DA, Dzutseva V, Parveen G, Zhu F, Leppan L, Langley JM, Barreto L, Gou J, Zhu T; CanSino COVID-19 Global Efficacy Study Group. Halperin SA, et al. Among authors: lioznov da. Lancet. 2022 Jan 15;399(10321):237-248. doi: 10.1016/S0140-6736(21)02753-7. Epub 2021 Dec 23. Lancet. 2022. PMID: 34953526 Free PMC article. Clinical Trial.
79 results